Collaborations & Alliances
Related Searches:
Filter by:
661 - 675 of 1089 results
November 23, 2009
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Astellas, expanded their antibody-drug conjugate (ADC) collaboration.
Read More »
November 20, 2009
Ligand Pharmaceuticals, Inc. has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck, through its research collaboration, which is due to expire at the end of December.
Read More »
November 17, 2009
PPD, Inc. has entered an agreement with Janssen Pharmaceutica to develop and commercialize two Phase II therapeutic compounds, one for diarrhea-predominant irritable bowel syndrome (IBS-d) and one for complicated skin and skin structure and respiratory in
Read More »
November 13, 2009
BioInvent International has entered into a license and discovery agreement with Daiichi Sankyo Co. for the development of therapeutic antibodies against multiple targets.
Read More »
November 11, 2009
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. entered into agreements to expand and extend their existing global collaboration established November 2007, to discover, develop, and commercialize therapeutic monoclonal antibodies.
Read More »
November 10, 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals, Inc. entered a global agreement for the development and commercialization of ALD518, a biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
Read More »
November 9, 2009
Evotec AG and Boehringer Ingelheim have extended their research collabration for four more years.
Read More »
November 5, 2009
Ligand Pharmaceuticals and Pfizer have extended their JAK3 research collaboration for another year.
Read More »
November 4, 2009
Emerson Resources, Inc. has formed a strategic partnership with Bio Research, a CRO specializing in agrichemical and related industries, to extend its business development capabilities.
Read More »
November 2, 2009
Amylin Pharmaceuticals and Takeda Pharmaceutical have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize compounds for the treatment of obesity and related indications.
Read More »
October 27, 2009
Scynexis, Inc. has received a payment from Merck for achieving a preclinical milestone in the companies’ oncology drug discovery and development collaboration.
Read More »
October 21, 2009
Xcellerex will help Novavax manufacture new H1N1 flu vaccine
Read More »
October 15, 2009
Evotec AG has extended its research collaboration with Ono Pharmaceutical Co., Ltd. and initiated a new discovery alliance.
Read More »
October 15, 2009
Azopharma and PharmaNet have formed a business development and co-promotion alliance
Read More »
October 14, 2009
Galapagos NV has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck to incorporate the development of new therapies for atherosclerosis
Read More »
661 - 675 of 1089 results
